nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Degarelix—Hypotension—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Degarelix—Palpitations—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Degarelix—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Degarelix—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Degarelix—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Degarelix—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Degarelix—Muscular weakness—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Degarelix—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Degarelix—Insomnia—Leflunomide—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Degarelix—Arthralgia—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Degarelix—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Degarelix—Dyspnoea—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Degarelix—Hypotension—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Degarelix—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Degarelix—Discomfort—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Degarelix—Vomiting—Mometasone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Degarelix—Dry mouth—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Degarelix—Feeling abnormal—Azathioprine—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Degarelix—Rash—Mometasone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Degarelix—Asthenia—Captopril—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Degarelix—Dermatitis—Mometasone—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Degarelix—Decreased appetite—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Degarelix—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Degarelix—Headache—Mometasone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Degarelix—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Degarelix—Insomnia—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Degarelix—Fatigue—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Degarelix—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Degarelix—Pruritus—Captopril—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Degarelix—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Degarelix—Constipation—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Degarelix—Pain—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Degarelix—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Degarelix—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Degarelix—Abdominal pain—Azathioprine—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Degarelix—Body temperature increased—Azathioprine—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Degarelix—Skin disorder—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Degarelix—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Degarelix—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Degarelix—Diarrhoea—Captopril—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Degarelix—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Degarelix—Erectile dysfunction—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Degarelix—Feeling abnormal—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Degarelix—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Degarelix—Fatigue—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Degarelix—Nausea—Mometasone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Degarelix—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Degarelix—Weight increased—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Degarelix—Pain—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Degarelix—Constipation—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Degarelix—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Degarelix—Weight decreased—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Degarelix—Hyperglycaemia—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Degarelix—Hypotension—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Degarelix—Dizziness—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Degarelix—Depression—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Degarelix—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Degarelix—Urticaria—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Degarelix—Abdominal pain—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Degarelix—Body temperature increased—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Degarelix—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Degarelix—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Degarelix—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Degarelix—Myocardial infarction—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Degarelix—Breast disorder—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Degarelix—Hypersensitivity—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Degarelix—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Degarelix—Insomnia—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Degarelix—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Degarelix—Vomiting—Captopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Degarelix—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Degarelix—Dyspnoea—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Degarelix—Rash—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Degarelix—Dermatitis—Captopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Degarelix—Headache—Captopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Degarelix—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Degarelix—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Degarelix—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Degarelix—Decreased appetite—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Degarelix—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Degarelix—Fatigue—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Degarelix—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Degarelix—Hypersensitivity—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Degarelix—Pain—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Degarelix—Constipation—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Degarelix—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Degarelix—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Degarelix—Diarrhoea—Azathioprine—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Degarelix—Nausea—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Degarelix—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Degarelix—Asthenia—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Degarelix—Feeling abnormal—Lisinopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Degarelix—Pruritus—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Degarelix—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Degarelix—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Degarelix—Dysuria—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Degarelix—Dizziness—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Degarelix—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Degarelix—Asthenia—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Degarelix—Diarrhoea—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Degarelix—Urticaria—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Degarelix—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Degarelix—Abdominal pain—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Degarelix—Body temperature increased—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Degarelix—Pruritus—Mycophenolic acid—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Degarelix—Vomiting—Azathioprine—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Degarelix—Eye disorder—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Degarelix—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Degarelix—Rash—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Degarelix—Dermatitis—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Degarelix—Depression—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Degarelix—Headache—Azathioprine—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Degarelix—Dizziness—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Degarelix—Renal failure—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Degarelix—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Degarelix—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Degarelix—Angiopathy—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Degarelix—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Degarelix—Immune system disorder—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Degarelix—Pain—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Degarelix—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Degarelix—Arrhythmia—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Degarelix—Vomiting—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Degarelix—Alopecia—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Degarelix—Hypersensitivity—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Degarelix—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Dizziness—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Rash—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Dermatitis—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Mental disorder—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Nausea—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Headache—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Degarelix—Malnutrition—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Degarelix—Erythema—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Degarelix—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Degarelix—Asthenia—Lisinopril—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Degarelix—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000988	0.000988	CcSEcCtD
Degarelix—Pruritus—Lisinopril—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Degarelix—Vomiting—Mycophenolic acid—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Degarelix—Rash—Mycophenolic acid—systemic scleroderma	0.000965	0.000965	CcSEcCtD
Degarelix—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000964	0.000964	CcSEcCtD
Degarelix—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Degarelix—Headache—Mycophenolic acid—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Degarelix—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Degarelix—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Degarelix—Nausea—Leflunomide—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Degarelix—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Degarelix—Vision blurred—Prednisone—systemic scleroderma	0.000945	0.000945	CcSEcCtD
Degarelix—Urethral disorder—Methotrexate—systemic scleroderma	0.000944	0.000944	CcSEcCtD
Degarelix—Diarrhoea—Lisinopril—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Degarelix—Ill-defined disorder—Prednisone—systemic scleroderma	0.000931	0.000931	CcSEcCtD
Degarelix—Anaemia—Prednisone—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Degarelix—Dizziness—Lisinopril—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Degarelix—Nausea—Mycophenolic acid—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Degarelix—Malaise—Prednisone—systemic scleroderma	0.000905	0.000905	CcSEcCtD
Degarelix—Eye disorder—Methotrexate—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Degarelix—Cardiac disorder—Methotrexate—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Degarelix—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Degarelix—Vomiting—Lisinopril—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Degarelix—Angiopathy—Methotrexate—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Degarelix—Immune system disorder—Methotrexate—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Degarelix—Rash—Lisinopril—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Degarelix—Dermatitis—Lisinopril—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Degarelix—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Degarelix—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Degarelix—Hypertension—Prednisone—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Degarelix—Chills—Methotrexate—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Degarelix—Headache—Lisinopril—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Degarelix—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Degarelix—Arthralgia—Prednisone—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Degarelix—Alopecia—Methotrexate—systemic scleroderma	0.000851	0.000851	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Degarelix—Discomfort—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Degarelix—Mental disorder—Methotrexate—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Degarelix—Malnutrition—Methotrexate—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Degarelix—Erythema—Methotrexate—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Degarelix—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Degarelix—Nausea—Lisinopril—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Degarelix—Anaphylactic shock—Prednisone—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Degarelix—Back pain—Methotrexate—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Degarelix—Nervous system disorder—Prednisone—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Degarelix—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Degarelix—Skin disorder—Prednisone—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Degarelix—Hyperhidrosis—Prednisone—systemic scleroderma	0.000792	0.000792	CcSEcCtD
Degarelix—Vision blurred—Methotrexate—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Degarelix—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Degarelix—Anaemia—Methotrexate—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Degarelix—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Degarelix—Rash—Mycophenolate mofetil—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Degarelix—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Degarelix—Headache—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Degarelix—Malaise—Methotrexate—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Degarelix—Insomnia—Prednisone—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Degarelix—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Degarelix—Arthralgia—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Degarelix—Decreased appetite—Prednisone—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Degarelix—Fatigue—Prednisone—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Degarelix—Discomfort—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Degarelix—Constipation—Prednisone—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Degarelix—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Degarelix—Feeling abnormal—Prednisone—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Degarelix—Nervous system disorder—Methotrexate—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Degarelix—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Degarelix—Skin disorder—Methotrexate—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Degarelix—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Degarelix—Urticaria—Prednisone—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Degarelix—Body temperature increased—Prednisone—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Degarelix—Abdominal pain—Prednisone—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Degarelix—Hypotension—Methotrexate—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Degarelix—Insomnia—Methotrexate—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Degarelix—Dyspnoea—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Degarelix—Hypersensitivity—Prednisone—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Degarelix—Decreased appetite—Methotrexate—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Degarelix—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000591	0.000591	CcSEcCtD
Degarelix—Fatigue—Methotrexate—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Degarelix—Asthenia—Prednisone—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Degarelix—Pain—Methotrexate—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Degarelix—Pruritus—Prednisone—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Degarelix—Feeling abnormal—Methotrexate—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Degarelix—Diarrhoea—Prednisone—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Degarelix—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Degarelix—Urticaria—Methotrexate—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Degarelix—Dizziness—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Degarelix—Abdominal pain—Methotrexate—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Degarelix—Body temperature increased—Methotrexate—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Degarelix—Vomiting—Prednisone—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Degarelix—Rash—Prednisone—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Degarelix—Dermatitis—Prednisone—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Degarelix—Headache—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Degarelix—Hypersensitivity—Methotrexate—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Degarelix—Asthenia—Methotrexate—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Degarelix—Nausea—Prednisone—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Degarelix—Pruritus—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Degarelix—Diarrhoea—Methotrexate—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Degarelix—Dizziness—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Degarelix—Vomiting—Methotrexate—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Degarelix—Rash—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Degarelix—Dermatitis—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Degarelix—Headache—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Degarelix—Nausea—Methotrexate—systemic scleroderma	0.000406	0.000406	CcSEcCtD
